Skip to Content

PharmaRoth Labs Inc ROTH Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ROTH

There is no Morningstar’s Analysis data available.

Key Statistics ROTH

Company Profile ROTH

Business Description

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

8250 West Charleston Boulevard, Suite 110
Las Vegas, NV, 89117
T +1 702 544-9960
Industry Biotechnology
Most Recent Earnings Mar 31, 2011
Fiscal Year End Jun 30, 2012
Employees 2